Device Trial Radar · NCT03926988
The Vesalio NeVa Stent Retriever Registry Study for Treatment of Large Vessel Occlusion Strokes
Last checked: Nov 20, 2026Latest source record: Nov 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
99
Actual
Start
Apr 1, 2019
Primary completion
Nov 30, 2024
Study completion Jan 31, 2025
Sponsor
- Lead sponsor
- VesalioNot on our public-company list
- Sponsor type
- Industry
- First posted
- Apr 25, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A prospective, open label, 90-day study designed to assess the safety, performance and efficacy of thrombus removal in subjects presenting with acute ischemic stroke with the NeVa stent retrievers.
Conditions
- Acute Ischemic Stroke
Interventions
NeVa Stent RetrieverDevice
mechanical neurothrombectomy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Recanalization rate of occluded target vesselTime frame: post-procedure day 0
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Vall d'Hebron
Barcelona, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.